Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV

Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV

(1) Background: Waning of neutralizing and cell-mediated immune response after the primary vaccine cycle (PVC) and the first booster dose (BD) is of concern, especially for PLWH with a CD4 count ≤200 cells/mm<sup>3</sup>. (2) Methods: Neutralizing antibodies (nAbs) titers by microneutral...

Full description

Bibliographic Details
Main Authors: Alessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, Stefania Cicalini, Veronica Bordoni, Silvia Meschi, Valentina Mazzotta, Francesca Colavita, Marisa Fusto, Eleonora Cimini, Stefania Notari, Veronica D’Aquila, Simone Lanini, Daniele Lapa, Roberta Gagliardini, Davide Mariotti, Giuseppina Giannico, Enrico Girardi, Francesco Vaia, Chiara Agrati, Fabrizio Maggi, Andrea Antinori
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Vaccines
Subjects:
HIV-1 infection
SARS-CoV-2 infection
neutralizing antibodies
mRNA vaccines
T cell immunity
immunity waning
Online Access:https://www.mdpi.com/2076-393X/11/12/1739

Internet

https://www.mdpi.com/2076-393X/11/12/1739

Similar Items